Indicators

Markets:

News

Latest News about AZN

Recent news which mentions AZN

...

26 27 28 29 30 31 32 33 Next >

Face Of US COVID-19 Response, Dr Anthony Fauci To Retire In December

August 22, 2022

AstraZeneca Slaps Lawsuit Against Former Employee As He Moves To Close Rival: Report

August 17, 2022

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

August 16, 2022

3 Top Stocks to Invest In Right Now

August 16, 2022

Benzinga Before The Bell: Elon Musk May Get Info It Wants From Twitter, Apple To Lay Off 100 Recruiter Contractors, Saudi's Investment Fund Picks Stocks Of US Big Tech And Other Top Financial Stories

August 16, 2022

UK Government Will Not Buy More AstraZeneca's COVID-19 Treatment

August 16, 2022

AstraZeneca-Merck's Prostate Cancer Drug Under FDA Priority Review For Expanded Use

August 16, 2022

Why Gilead Sciences Stock Was a 5% Winner Today

August 15, 2022

Benzinga Before The Bell: YouTube Plans Streaming Marketplace, Drug Pricing Bill Passes Congress, Bitcoin Could Surge To All-Time High Soon And Other Top Financial Stories Monday, August 15

August 15, 2022

Landmark Drug Pricing Reform Bill Passes Congress House

August 15, 2022

AstraZeneca-Daiichi's Flagship Breast Cancer Drug Improves Survival In Late-Stage Study

August 15, 2022

Recap Of Friday's Biotech Catalysts - End Of the Day Summary

August 12, 2022

Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation

August 12, 2022

This Analyst Says Zentalis' Increased Focus On WEE1 Program Is 'Prudent', Slashes Price Target By 37%

August 10, 2022

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful

August 09, 2022

AstraZeneca's Dato-DXd-Based Combo Therapies Show Promising Activity In Lung Cancer Patients

August 09, 2022

Recap of Monday's Biotech Catalysts - End Of the Day Summary

August 08, 2022

AstraZeneca (AZN) Announces Approval of ENHERTU (HER2-low Metastatic Breast Cancer) in the United States

August 08, 2022

Lyme Disease And Climate Change Reinvigorates Valneva's Vaccine Efforts After COVID Shot Disappointment

August 08, 2022

Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders

August 08, 2022

AstraZeneca's Tagrisso Doublet Therapy Shows 49% Response Rate In Lung Cancer Setting

August 08, 2022

3 Unstoppable Stocks That Don't Care About the Bear Market

August 07, 2022

Pharmaceutical CEOs use earnings calls to criticize drug-pricing proposal

August 05, 2022

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

August 04, 2022

Pieris Stops Work On Cancer Med, Tested In Combo With Eli Lilly Drugs

August 04, 2022

AstraZeneca and Merck Receives European Commission Approval For Expanded Use In Breast Cancer Therapy

August 04, 2022

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate

August 04, 2022

Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus

August 02, 2022

Avalo Therapeutics, Apollo Therapeutics Ink Pact For Anti-IL-18 Antibody

August 01, 2022

Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial

August 01, 2022

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.